Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1002/cbic.202100209 http://scihub22266oqcxt.onion/10.1002/cbic.202100209 34132013!8426704!34132013     free     free     free Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Chembiochem 2021 ; 22 (15): 2516-2520 Nephropedia Template TP {{tp|p=34132013|t=2021. alpha(V) beta(6) Integrin: An Intriguing Target for COVID-19 and Related Diseases |pdf=|usr=}}{{34132013}} gab.com Text alpha(V) beta(6) Integrin: An Intriguing Target for COVID-19 and Related Diseases JO: Chembiochem http://www.kidney.de/pget.php?&tw=1&pmid=34132013 #FOAvip The outbreak of SARS-CoV-2 has been an extraordinary event that constituted a global health emergency. As the novel coronavirus is continuing to spread over the world, the need for therapeutic agents to control this pandemic is increasing. alpha(V) beta(6) Integrin may be an intriguing target not only for the inhibition of SARS-CoV-2 entry, but also for the diagnosis/treatment of COVID-19 related fibrosis, an emerging type of fibrotic disease which will probably affect a significant part of the recovered patients. In this short article, the possible role of this integrin for fighting COVID-19 is discussed on the basis of recently published evidence, showing how its underestimated involvement may be interesting for the development of novel pharmacological tools. Twit Text FOAVip alpha(V) beta(6) Integrin: An Intriguing Target for COVID-19 and Related Diseases ????Chembiochem http://www.kidney.de/pget.php?&tw=1&pmid=34132013 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34132013 #FOAvip English Wikipedia <ref>{{Cite pmid|34132013}}</ref> alpha(V) beta(6) Integrin: An Intriguing Target for COVID-19 and Related Diseases #MMPMID34132013 Bugatti K Chembiochem 2021[Aug]; 22 (15): 2516-2520 PMID34132013show ga The outbreak of SARS-CoV-2 has been an extraordinary event that constituted a global health emergency. As the novel coronavirus is continuing to spread over the world, the need for therapeutic agents to control this pandemic is increasing. alpha(V) beta(6) Integrin may be an intriguing target not only for the inhibition of SARS-CoV-2 entry, but also for the diagnosis/treatment of COVID-19 related fibrosis, an emerging type of fibrotic disease which will probably affect a significant part of the recovered patients. In this short article, the possible role of this integrin for fighting COVID-19 is discussed on the basis of recently published evidence, showing how its underestimated involvement may be interesting for the development of novel pharmacological tools. |COVID-19/metabolism/pathology/*virology[MESH] |Fibrosis/metabolism/pathology/*virology[MESH] |Humans[MESH] |Integrin beta Chains/*metabolism[MESH]alpha(V) beta(6) Integrin: An Intriguing Target for COVID-19 and Relat(epmc).pdf DeepDyve Pubget Overpricing